13F

AQST AQUESTIVE THERAPEUTICS INC

2026Q1 · CUSIP 03843E104 · Sector: Healthcare & Biotech

Neutral · No signal
Holders
174
Δ holders QoQ
-2
Breadth percentile
Top 70%
Whale holders
82
Δ whales
-5
Inst. holding value
$289M
New positions
46
Closed positions
48
Price momentum (1Q)
+6.6%
Put / Call
3/3

Breadth history (34 quarters)

2018Q4: Δ-8 · h=37 2019Q1: Δ+13 · h=50 2019Q2: Δ-9 · h=41 2019Q3: Δ-5 · h=36 2019Q4: Δ+22 · h=58 2020Q1: Δ-15 · h=43 2020Q2: Δ+15 · h=58 2020Q3: Δ+2 · h=60 2020Q4: Δ+6 · h=66 2021Q1: Δ-2 · h=64 2021Q2: Δ-3 · h=61 2021Q3: Δ-14 · h=47 2021Q4: Δ+5 · h=52 2022Q1: Δ-2 · h=50 2022Q2: Δ-4 · h=46 2022Q3: Δ+1 · h=47 2022Q4: Δ-9 · h=38 2023Q1: Δ-2 · h=36 2023Q2: Δ+19 · h=55 2023Q3: Δ-6 · h=49 2023Q4: Δ+8 · h=57 2024Q1: Δ+40 · h=97 2024Q2: Δ+0 · h=97 2024Q3: Δ+19 · h=116 2024Q4: Δ-2 · h=114 2025Q1: Δ+7 · h=121 2025Q2: Δ-4 · h=117 2025Q3: Δ+35 · h=152 2025Q4: Δ+24 · h=176 2026Q1: Δ-2 · h=174 2018Q4: holders=37 2019Q1: holders=50 2019Q2: holders=41 2019Q3: holders=36 2019Q4: holders=58 2020Q1: holders=43 2020Q2: holders=58 2020Q3: holders=60 2020Q4: holders=66 2021Q1: holders=64 2021Q2: holders=61 2021Q3: holders=47 2021Q4: holders=52 2022Q1: holders=50 2022Q2: holders=46 2022Q3: holders=47 2022Q4: holders=38 2023Q1: holders=36 2023Q2: holders=55 2023Q3: holders=49 2023Q4: holders=57 2024Q1: holders=97 2024Q2: holders=97 2024Q3: holders=116 2024Q4: holders=114 2025Q1: holders=121 2025Q2: holders=117 2025Q3: holders=152 2025Q4: holders=176 2026Q1: holders=174 -40 -20 +0 +20 +40 32109185 18Q419Q320Q221Q121Q422Q323Q224Q124Q425Q326Q1 Δ holders (bar) Holders (line)

Past Lit Events & Aftermath 4 lit events

Period Percentile Next-1Q return Next-2Q return
2025Q3 Top 8% -32.0% -28.4%
2024Q3 Top 18% -35.1% -50.6%
2024Q1 Top 5% +37.0% +42.8%
2023Q2 Top 11% -11.0% +49.5%

Options Sentiment

Put holders
3
QoQ: -5
Call holders
3
QoQ: -3

See methodology →

Fundamentals

PE (TTM)
EPS (TTM)
$-0.61
EPS YoY
Revenue (TTM)
$0.1B
Revenue YoY
-7.3%
Quarterly Revenue & EPS (4Y)
2022-06-30: $13M 2022-09-30: $11M 2022-12-31: $11M 2023-03-31: $11M 2023-06-30: $13M 2023-09-30: $13M 2023-12-31: $13M 2024-03-31: $12M 2024-06-30: $20M 2024-09-30: $14M 2024-12-31: $12M 2025-03-31: $9M 2025-06-30: $10M 2025-09-30: $13M 2025-12-31: $13M 2026-03-31: $14M 2022-06-30: EPS -0.36 2022-09-30: EPS -0.23 2022-12-31: EPS -0.21 2023-03-31: EPS 0.11 2023-06-30: EPS -0.10 2023-09-30: EPS -0.03 2023-12-31: EPS -0.11 2024-03-31: EPS -0.17 2024-06-30: EPS -0.03 2024-09-30: EPS -0.13 2024-12-31: EPS -0.18 2025-03-31: EPS -0.24 2025-06-30: EPS -0.14 2025-09-30: EPS -0.14 2025-12-31: EPS -0.26 2026-03-31: EPS -0.07 0M 10M 20M $M -0.40 -0.14 0.12 20222023202420252026 Revenue EPS

Quarterly figures; EPS split-adjusted, early quarters hidden when not calibrable

As of 2026-03-31 · SEC filings (XBRL)